# Flowers Foods Inc: overview

FLO · NYSE · CIK 1128928 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/flo.md) · [Financials](/companies/flo/financials.md) · [Filings](/companies/flo/filings.md) · [Insiders](/companies/flo/insiders.md)

Latest reported revenue: [$1.19bn](/filings/0001193125-26-359192.md) for Q2 FY2026, three months to 2026-07-18, from the 10-Q filed Aug 20, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-359192).

## Last eight quarters

| Line item | Unit | Q4 FY2023 (2023-12-30) | Q2 FY2024 (2024-07-13) | Q3 FY2024 (2024-10-05) | Q4 FY2024 (2024-12-28) | Q2 FY2025 (2025-07-12) | Q3 FY2025 (2025-10-04) | Q4 FY2025 (2026-01-03) | Q2 FY2026 (2026-07-18) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,129 d](/filings/0001193125-26-071441.md) | [1,225](/filings/0001193125-25-181262.md) | [1,191](/filings/0001193125-25-269546.md) | [1,111 d](/filings/0001193125-26-071441.md) | [1,243](/filings/0001193125-26-359192.md) | [1,227](/filings/0001193125-25-269546.md) | [1,233 d](/filings/0001193125-26-071441.md) | [1,193](/filings/0001193125-26-359192.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [4.4% d](/filings/0001193125-26-071441.md) | [7.8%](/filings/0001193125-25-181262.md) | [7.6%](/filings/0001193125-25-269546.md) | [5.5% d](/filings/0001193125-26-071441.md) | [7.5%](/filings/0001193125-26-359192.md) | [5.4%](/filings/0001193125-25-269546.md) | [(5.8%) d](/filings/0001193125-26-071441.md) | [5.7%](/filings/0001193125-26-359192.md) |
| Net margin | % | [3.2% d](/filings/0001193125-26-071441.md) | [5.5%](/filings/0001193125-25-181262.md) | [5.5%](/filings/0001193125-25-269546.md) | [3.9% d](/filings/0001193125-26-071441.md) | [4.7%](/filings/0001193125-26-359192.md) | [3.2%](/filings/0001193125-25-269546.md) | [(5.4%) d](/filings/0001193125-26-071441.md) | [3.4%](/filings/0001193125-26-359192.md) |
| Diluted EPS | $ per share | not reported | [0.32](/filings/0001193125-25-181262.md) | [0.31](/filings/0001193125-25-269546.md) | not reported | [0.28](/filings/0001193125-26-359192.md) | [0.19](/filings/0001193125-25-269546.md) | not reported | [0.19](/filings/0001193125-26-359192.md) |
| Free cash flow | $m | [60.0 d](/filings/0001193125-26-071441.md) | not reported | [88.6 d](/filings/0001193125-25-269546.md) | [84.8 d](/filings/0001193125-26-071441.md) | not reported | [30.4 d](/filings/0001193125-25-269546.md) | [78.6 d](/filings/0001193125-26-071441.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-01) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2026-01-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,331](/filings/0000950170-24-017647.md) | [4,806](/filings/0000950170-25-022243.md) | [5,091](/filings/0001193125-26-071441.md) | [5,103](/filings/0001193125-26-071441.md) | [5,256](/filings/0001193125-26-071441.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [6.8%](/filings/0000950170-24-017647.md) | [6.3%](/filings/0000950170-25-022243.md) | [3.4%](/filings/0001193125-26-071441.md) | [6.8%](/filings/0001193125-26-071441.md) | [3.3%](/filings/0001193125-26-071441.md) |
| Net margin | % | [4.8%](/filings/0000950170-24-017647.md) | [4.8%](/filings/0000950170-25-022243.md) | [2.4%](/filings/0001193125-26-071441.md) | [4.9%](/filings/0001193125-26-071441.md) | [1.6%](/filings/0001193125-26-071441.md) |
| Diluted EPS | $ per share | [0.97](/filings/0000950170-24-017647.md) | [1.07](/filings/0000950170-25-022243.md) | [0.58](/filings/0001193125-26-071441.md) | [1.17](/filings/0001193125-26-071441.md) | [0.40](/filings/0001193125-26-071441.md) |
| Free cash flow | $m | [209](/filings/0000950170-24-017647.md) | [192](/filings/0000950170-25-022243.md) | [220](/filings/0001193125-26-071441.md) | [281](/filings/0001193125-26-071441.md) | [319](/filings/0001193125-26-071441.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/flo/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $273.6m | 34,631,216 |  | Added +14,612,794 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $109.1m | 13,811,454 |  | Added +3,053,268 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $86.8m | 10,983,938 |  | Reduced −364,874 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $69.7m | 8,826,026 |  | Added +94,851 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $69.2m | 8,756,329 |  | Reduced −3,211,278 |
| [Quantinno Capital Management LP](/funds/1759654.md) | 2026-06-30 | $67.4m | 8,527,936 |  | Added +5,131,382 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $64.8m | 8,196,732 |  | Added +1,679,440 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $58.8m | 7,444,845 |  | Added +2,189,100 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $56.6m | 7,163,993 |  | Added +2,821,864 |
| [Gotham Asset Management, LLC](/funds/1510387.md) | 2026-06-30 | $52.5m | 6,650,995 |  | Added +6,174,229 |

## Recent filings

[All 1,416 filings](/companies/flo/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 20:05 ET | [8-K](/filings/0001193125-26-374329.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-374329 |
| 2026-08-20 | 20:10 ET | [10-Q](/filings/0001193125-26-359192.md) | Quarterly report, period 2026-07-18 | 0001193125-26-359192 |
| 2026-08-20 | 20:10 ET | [8-K](/filings/0001193125-26-359191.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-359191 |
| 2026-06-05 | 20:45 ET | [8-K](/filings/0001193125-26-259809.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-259809 |
| 2026-06-02 | 20:44 ET | [8-K](/filings/0001193125-26-253700.md) | 5.07 Shareholder vote results | 0001193125-26-253700 |
| 2026-05-21 | 20:15 ET | [10-Q](/filings/0001193125-26-234437.md) | Quarterly report, period 2026-04-25 | 0001193125-26-234437 |
| 2026-05-21 | 20:10 ET | [8-K](/filings/0001193125-26-234421.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234421 |
| 2026-04-14 | 15:30 ET | [DEF 14A](/filings/0001104659-26-043025.md) | Proxy statement, period 2026-05-29 | 0001104659-26-043025 |
| 2026-04-07 | 20:35 ET | [8-K](/filings/0001193125-26-145638.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-145638 |
| 2026-03-30 | 13:09 ET | [8-K](/filings/0001193125-26-130523.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-130523 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 3, 2026](/filings/0001193125-26-071441.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1128928
- Tickers: FLO
- Exchange: NYSE
- SIC code: 2000 Food and Kindred Products
- State of incorporation: GA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.